Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth
Authors
Keywords
Nasopharyngeal carcinoma, CIP2A, Proliferation, Cell growth, Survival
Journal
Molecular Cancer
Volume 13, Issue 1, Pages 111
Publisher
Springer Nature
Online
2014-05-19
DOI
10.1186/1476-4598-13-111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CIP2A oncoprotein controls cell growth and autophagy through mTORC1 activation
- (2014) Pietri Puustinen et al. JOURNAL OF CELL BIOLOGY
- Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of Ch
- (2013) Yong Chen et al. CANCER
- CIP2A Modulates Cell-Cycle Progression in Human Cancer Cells by Regulating the Stability and Activity of Plk1
- (2013) J.-S. Kim et al. CANCER RESEARCH
- Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging Human Oncoprotein and a Potential Cancer Therapy Target
- (2013) A. Khanna et al. CANCER RESEARCH
- CIP2A Influences Survival in Colon Cancer and Is Critical for Maintaining Myc Expression
- (2013) Armin Wiegering et al. PLoS One
- Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1
- (2013) Anni Laine et al. Cancer Discovery
- Nasopharyngeal carcinoma incidence and mortality in China in 2009
- (2013) Zhi-Jian Xu et al. Chinese Journal of Cancer
- MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma
- (2012) Na Liu et al. CANCER LETTERS
- CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes
- (2012) M Niemelä et al. ONCOGENE
- Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression
- (2011) C. M. Lucas et al. BLOOD
- Prognostic role of CIP2A expression in serous ovarian cancer
- (2011) C Böckelman et al. BRITISH JOURNAL OF CANCER
- Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients’ survival
- (2011) J Ren et al. BRITISH JOURNAL OF CANCER
- High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer
- (2011) C Böckelman et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation
- (2011) D P Mathiasen et al. ONCOGENE
- ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells
- (2011) Anchit Khanna et al. PLoS One
- CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis
- (2010) Qian-Ze Dong et al. ANNALS OF SURGICAL ONCOLOGY
- CIP2A increases self-renewal and is linked to Myc in neural progenitor cells
- (2010) Laura Kerosuo et al. DIFFERENTIATION
- How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?
- (2010) Shu-Zhen Lai et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells
- (2010) K-F Chen et al. ONCOGENE
- MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric Cancer
- (2009) Anchit Khanna et al. JNCI-Journal of the National Cancer Institute
- CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence, or Differentiation of Tumor Cells
- (2008) W. Li et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started